- $30.76m
- $35.32m
- $0.03m
Brief: Impact Biomedical Says On July 21 Entered Debt Conversion Agreement With DSS
Brief: Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger
Brief: Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease
Brief: Impact Biomedical Inc. Announces Pricing Of Initial Public Offering